New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
基本信息
- 批准号:10649771
- 负责人:
- 金额:$ 68.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-23 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAddressAnti-Bacterial AgentsAutoimmune DiseasesBacteriaBacterial Antibiotic ResistanceBacterial GenesBacterial InfectionsBinding ProteinsBiochemicalBiologicalCellsCommunicable DiseasesDataDevelopmentFamilyFrancisella tularensisGene FamilyGenesGenetic PolymorphismGoalsHomologous GeneHost DefenseHumanIRF1 geneImmuneImpairmentIn VitroInfectionInflammatoryInnate Immune ResponseInterferon Type IInterferonsKnock-in MouseKnowledgeLengthLigaseLinkListeria monocytogenesMacrophageMediatingMediatorModelingMolecularMusNatural ImmunityOrthologous GenePlayPopulationPredispositionProductionProtein FamilyProtein IsoformsProtein Synthesis InhibitionProteinsPublishingRNA DegradationRegulationRibonucleasesRoleSignal TransductionTestingTransferaseTranslationsUp-RegulationViralViral PhysiologyVirus Diseasesantimicrobialcell typecytokinedesignexperimental studygenome wide association studyguanylatein vivoinnate immune functioninnovationinsightmembermouse modelnovel therapeutic interventionoligoadenylateresponsetranscription factor
项目摘要
ABSTRACT
Type I interferons (IFN) and IFN stimulated genes (ISGs) provide broad antiviral activities. However, the host
protection provided by the IFN and ISGs during bacterial infections is not well defined. This proposal will define
new innate immune functions of Oligoadenylate Synthetase (OAS) proteins against intracellular bacterial
infections. OASs are a family of ISG that belongs to an evolutionarily ancient family of nucleotidyl-transferases
(NTase). The canonical antiviral mechanism of OAS proteins involves the enzymatic synthesis of 2'-5'-
oligoadenylates, causing downstream activation of RNase L, leading to RNA degradation and inhibition of
protein synthesis. However, the host protective function of multiple enzymatically active and inactive OAS
isoforms during bacterial infection is not known. This proposal will address this knowledge gap to define the
innate antibacterial functions of two OAS family proteins, OAS1 and OASL. Our preliminary studies suggest that
human OAS1 and a mouse ortholog, Oas1b, confer protection from infection with intracellular bacteria by
enhancing the expression of several proteins including IRF1, a major antibacterial transcription factor.
Furthermore, we found that mice lacking Oasl2 (ortholog of human OASL), another member of OAS family, are
highly susceptible to intracellular bacterial infection, and show increased production of host-detrimental
inflammatory cytokines. Based on these preliminary findings, we hypothesize that specific members of OAS-
family proteins contribute to host defense against intracellular bacteria through unique NTase activity-
independent mechanisms. The goal of this proposal is to determine the innate antibacterial functions of two OAS
family proteins and the underlying mechanisms in three independent aims: (1) Identify the mechanisms of cell-
intrinsic antibacterial activity of OAS1. Here, we will define the molecular mechanism by which OAS1 mediates
cell intrinsic antibacterial defense using in vitro biochemical and cell biological approaches. (2) Determine the in
vivo role of Oas1b in anti-bacterial innate immunity. We will use a newly generated Oas1b knock-in mouse model
to identify the in vivo mediators and cell-type specific antibacterial function of Oas1b. (3) Define the role of OASL
in host defense against intracellular bacterial infections and the underlying molecular mechanism(s). Taken
together, this proposal is designed to elucidate new NTase activity-independent molecular functions of OAS
proteins, and to integrate it with antibacterial cellular defense in an innovative functional-model. Upon completion
of this study, we will establish a new paradigm of innate host defense orchestrated by OAS proteins that may
lead to new therapeutic strategies.
摘要
I型干扰素(IFN)和IFN刺激基因(ISG)提供广泛的抗病毒活性。然而,东道主
IFN和ISG在细菌感染期间提供的保护作用还没有很好地确定。该提案将定义
寡腺苷酸合成酶(OAS)蛋白抗细胞内细菌的新天然免疫功能
感染. OAS是ISG的一个家族,属于进化上古老的核苷酸转移酶家族
(NTase)。OAS蛋白的典型抗病毒机制涉及2 '-5'-
寡聚腺苷酸,引起下游RNase L的激活,导致RNA降解和抑制
蛋白质合成。然而,多种酶活性和失活的OAS的宿主保护功能,
在细菌感染期间的同种型是未知的。本提案将解决这一知识差距,
两种OAS家族蛋白OAS 1和OASL的先天抗菌功能。我们的初步研究表明,
人OAS 1和小鼠直系同源物Oas 1b通过以下方式提供保护,使其免受细胞内细菌感染:
增强几种蛋白质的表达,包括IRF 1,一种主要的抗菌转录因子。
此外,我们发现缺乏OAS家族的另一个成员Oasl 2(人OASL的直系同源物)的小鼠,
对细胞内细菌感染高度敏感,并显示宿主有害的
炎性细胞因子基于这些初步发现,我们假设美洲国家组织的特定成员-
家族蛋白通过独特的NTase活性有助于宿主防御细胞内细菌,
独立的机制。本提案的目的是确定两种OAS的先天抗菌功能
家族蛋白及其潜在机制的三个独立的目标:(1)确定细胞的机制,
OAS 1的内在抗菌活性。在这里,我们将定义OAS 1介导的分子机制,
使用体外生物化学和细胞生物学方法的细胞内在抗菌防御。(2)确定输入
Oas 1b在抗细菌先天免疫中的体内作用。我们将使用新生成的Oas 1b基因敲入小鼠模型
鉴定Oas 1b的体内介质和细胞类型特异性抗菌功能。(3)定义OASL的作用
在宿主防御细胞内细菌感染和潜在的分子机制。采取
总之,这一建议旨在阐明新的非NTase活性依赖的OAS分子功能
蛋白质,并将其与创新功能模型中的抗菌细胞防御相结合。完成后
在这项研究中,我们将建立一个由OAS蛋白编排的先天宿主防御的新范式,
导致新的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vijay Rathinam其他文献
Vijay Rathinam的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vijay Rathinam', 18)}}的其他基金
Host-derived extracellular vesicles in inflammatory caspase activation
宿主来源的细胞外囊泡在炎症半胱天冬酶激活中的作用
- 批准号:
9973550 - 财政年份:2020
- 资助金额:
$ 68.67万 - 项目类别:
Host-derived extracellular vesicles in inflammatory caspase activation
宿主来源的细胞外囊泡在炎症半胱天冬酶激活中的作用
- 批准号:
10535447 - 财政年份:2020
- 资助金额:
$ 68.67万 - 项目类别:
Host-derived extracellular vesicles in inflammatory caspase activation
宿主来源的细胞外囊泡在炎症半胱天冬酶激活中的作用
- 批准号:
10318094 - 财政年份:2020
- 资助金额:
$ 68.67万 - 项目类别:
Cytosolic Immune Surveillance During Bacterial Infections
细菌感染期间的细胞质免疫监视
- 批准号:
10416062 - 财政年份:2016
- 资助金额:
$ 68.67万 - 项目类别:
Cytosolic Immune Surveillance During Bacterial Infections
细菌感染期间的细胞质免疫监视
- 批准号:
10306046 - 财政年份:2016
- 资助金额:
$ 68.67万 - 项目类别:
Cytosolic Immune Surveillance During Bacterial Infections
细菌感染期间的细胞质免疫监视
- 批准号:
10625492 - 财政年份:2016
- 资助金额:
$ 68.67万 - 项目类别:
Cytosolic Immune Surveillance During Bacterial Infections
细菌感染期间的细胞质免疫监视
- 批准号:
9225153 - 财政年份:2016
- 资助金额:
$ 68.67万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 68.67万 - 项目类别:
Research Grant